X Facebook LinkedIn WhatsApp Press Releases (-) Any 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2017 August 7, 2017 argenx to present at Wedbush PacGrow Healthcare Conference July 6, 2017 argenx presents full data from ARGX-111 Phase Ib study in patients with advanced cancers over-expressing the MET protein at Best of ASCO Asia 2017 (Singapore) June 19, 2017 argenx receives second preclinical milestone payment in collaboration with LEO Pharma June 13, 2017 argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas at the International Conference of Malignant Lymphoma (ICML) June 12, 2017 argenx to Present at JMP Securities Life Sciences Conference May 22, 2017 argenx announces closing of NASDAQ IPO May 18, 2017 argenx announces full exercise of underwriters’ option to purchase additional ADSs May 16, 2017 argenx raises approximately $100 million gross proceeds with NASDAQ IPO May 15, 2017 argenx announces size of initial public offering in the United States increased to 5 million ADSs May 7, 2017 argenx announces launch of proposed initial public offering in the United States May 7, 2017 argenx announces launch of proposed initial public offering in the United States May 3, 2017 argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in myasthenia gravis Pagination First page « First Previous page ‹ Previous … Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Page 23 Page 24 Page 25 … Next page Next › Last page Last »